These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 21954478)

  • 21. A detailed safety assessment of a saw palmetto extract.
    Avins AL; Bent S; Staccone S; Badua E; Padula A; Goldberg H; Neuhaus J; Hudes E; Shinohara K; Kane C
    Complement Ther Med; 2008 Jun; 16(3):147-54. PubMed ID: 18534327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.
    Lopatkin N; Sivkov A; Walther C; Schläfke S; Medvedev A; Avdeichuk J; Golubev G; Melnik K; Elenberger N; Engelmann U
    World J Urol; 2005 Jun; 23(2):139-46. PubMed ID: 15928959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gerber GS; Fitzpatrick JM
    BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. R. Shi, Q. Xie, X. Gang, J. Lun, L. Cheng, A. Pantuck and J. Rao. J Urol 2008; 179: 610-615.
    Ozdemir AT; Serefoglu EC; Balbay MD
    J Urol; 2008 Sep; 180(3):1188; author reply 1188. PubMed ID: 18639898
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
    Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
    BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saw palmetto and lower urinary tract symptoms: what is the latest evidence?
    Avins AL; Bent S
    Curr Urol Rep; 2006 Jul; 7(4):260-5. PubMed ID: 16930496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study.
    McPartland JM; Pruitt PL
    J Am Osteopath Assoc; 2000 Feb; 100(2):89-96. PubMed ID: 10732392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial.
    Lopatkin N; Sivkov A; Schläfke S; Funk P; Medvedev A; Engelmann U
    Int Urol Nephrol; 2007; 39(4):1137-46. PubMed ID: 18038253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms.
    Barry MJ; Cantor A; Roehrborn CG;
    J Urol; 2013 Mar; 189(3):987-92. PubMed ID: 23017510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
    Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
    Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
    Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
    BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
    Yamada S; Shirai M; Ono K; Kageyama S
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
    Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
    Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
    Sökeland J
    BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial.
    Song J; Lee SH; Kim H
    Medicine (Baltimore); 2019 Nov; 98(45):e17848. PubMed ID: 31702643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.